NOT FOR DISTRIBUTION
Header cover image

Beijing Balance Medical TechnologyLtd

Market Cap

CN¥13.7b

Last Updated

2021/04/11 09:03 UTC

Data Sources

Company Financials

Executive Summary

Beijing Balance Medical Technology Co.,Ltd. More Details

Risk Analysis

Volatile share price over the past 3 months



Snowflake Analysis

Flawless balance sheet with questionable track record.

Share Price & News

How has Beijing Balance Medical TechnologyLtd's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 688198 is more volatile than 75% of CN stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: 688198's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.


Market Performance


7 Day Return

-2.5%

688198

2.5%

CN Biotechs

-1.1%

CN Market


1 Year Return

216.4%

688198

39.3%

CN Biotechs

28.4%

CN Market

Return vs Industry: 688198 exceeded the CN Biotechs industry which returned 35.6% over the past year.

Return vs Market: 688198 exceeded the CN Market which returned 27.4% over the past year.


Shareholder returns

688198IndustryMarket
7 Day-2.5%2.5%-1.1%
30 Day14.3%9.2%1.0%
90 Day88.3%0.3%-5.8%
1 Year216.9%216.4%39.8%39.3%30.4%28.4%
3 Yearn/a80.7%78.0%25.9%19.9%
5 Yearn/a61.2%58.2%23.6%15.5%

Long-Term Price Volatility Vs. Market

How volatile is Beijing Balance Medical TechnologyLtd's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Beijing Balance Medical TechnologyLtd undervalued compared to its fair value and its price relative to the market?

246.64x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 688198 (CN¥143.05) is trading above our estimate of fair value (CN¥11.6)

Significantly Below Fair Value: 688198 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 688198 is poor value based on its PE Ratio (246.6x) compared to the CN Biotechs industry average (56x).

PE vs Market: 688198 is poor value based on its PE Ratio (246.6x) compared to the CN market (34.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 688198's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 688198 is overvalued based on its PB Ratio (17.1x) compared to the CN Biotechs industry average (6.1x).


Future Growth

How is Beijing Balance Medical TechnologyLtd forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

28.6%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Beijing Balance Medical TechnologyLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Beijing Balance Medical TechnologyLtd performed over the past 5 years?

17.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 688198 has high quality earnings.

Growing Profit Margin: 688198's current net profit margins (30.8%) are lower than last year (43.2%).


Past Earnings Growth Analysis

Earnings Trend: 688198's earnings have grown by 17.3% per year over the past 5 years.

Accelerating Growth: 688198's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688198 had negative earnings growth (-11.1%) over the past year, making it difficult to compare to the Biotechs industry average (16.3%).


Return on Equity

High ROE: 688198's Return on Equity (7%) is considered low.


Financial Health

How is Beijing Balance Medical TechnologyLtd's financial position?


Financial Position Analysis

Short Term Liabilities: 688198's short term assets (CN¥769.4M) exceed its short term liabilities (CN¥19.9M).

Long Term Liabilities: 688198's short term assets (CN¥769.4M) exceed its long term liabilities (CN¥3.8M).


Debt to Equity History and Analysis

Debt Level: 688198 is debt free.

Reducing Debt: 688198 has not had any debt for past 5 years.

Debt Coverage: 688198 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 688198 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Beijing Balance Medical TechnologyLtd current dividend yield, its reliability and sustainability?

0.14%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 688198's dividend (0.14%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.42%).

High Dividend: 688198's dividend (0.14%) is low compared to the top 25% of dividend payers in the CN market (1.79%).


Stability and Growth of Payments

Stable Dividend: 688198 is not paying a notable dividend for the CN market, therefore no need to check if payments are stable.

Growing Dividend: 688198 is not paying a notable dividend for the CN market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: 688198 is not paying a notable dividend for the CN market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 688198's dividend in 3 years as they are not forecast to pay a notable one for the CN market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Beijing Balance Medical TechnologyLtd has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Beijing Balance Medical Technology Co.,Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Beijing Balance Medical Technology Co.,Ltd.
  • Ticker: 688198
  • Exchange: SHSE
  • Founded: 2005
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CN¥13.733b
  • Shares outstanding: 96.00m
  • Website: https://www.bairenmedical.com

Number of Employees


Location

  • Beijing Balance Medical Technology Co.,Ltd.
  • Science Park
  • No. 2, Huachang Road
  • Beijing
  • 102200
  • China

Listings


Biography

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, and production of animal-derived implantable medical devices in China. The company offers artificial biological heart va...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/11 09:03
End of Day Share Price2021/04/09 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.